Merger • Life Science

NuvinkaDx Acquires GeneProof

On April 21, 2022, NuvinkaDx acquired life science company GeneProof

Acquisition Context
  • This is NuvinkaDx’s 1st transaction in the Life Science sector.
  • This is NuvinkaDx’s 1st transaction in Czech Republic.

Explore All 192 Merger Life Science Deals - Search the Database Free


M&A Deal Summary

Date April 21, 2022
Target GeneProof
Sector Life Science
Buyer(s) NuvinkaDx
Deal Type Merger

Target Company

GeneProof

Brno, Czech Republic
GeneProof is a molecular diagnostics company. GeneProof is a producer of PCR reagents and distributes its portfolio of more than 70 CE-marked molecular diagnostic tests and instruments throughout Europe, Africa, the Middle East, and South America. GeneProof was founded in 2005 and is based in Brno, Czech Republic.
Explore More Deals

Browse All 215,262 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

NuvinkaDx

Salem, New Hampshire, United States

Category Company
Sector Life Science
DESCRIPTION

NuvinkaDx is a global diagnostics company, brings established expertise in immunodiagnostics and molecular diagnostics. NuvinkaDx is based in Salem, New Hampshire.


Deal Context for Buyer #
Overall 2 of 2
Sector: Life Science 1 of 1
Type: Merger 2 of 2
Country: Czech Republic 1 of 1
Year: 2022 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-04-21 ALPCO

Salem, New Hampshire, United States

ALPCO is an importer and distributor of immunoassay-based products for the North American life science markets. ALPCO is a provider of proprietary and distributed diagnostics solutions, with over 60 collaborating partners from around the globe. ALPCO was founded in 1990 and is based in Salem, New Hampshire.

Buy -

Explore Related M&A Activity